about
Non-targeted effects of ionising radiation--implications for low dose risk.Gold nanoparticles for cancer radiotherapy: a reviewDNA damage responses following exposure to modulated radiation fieldsBiological mechanisms of gold nanoparticle radiosensitization.An improved method for the treatment of data from DNA strand break measurements using filter elution techniques with an internal standard.Estrogen enhanced cell-cell signalling in breast cancer cells exposed to targeted irradiation.Radiation microbeams as spatial and temporal probes of subcellular and tissue response.Akt/mTOR mediated induction of bystander effect signaling in a nucleus independent manner in irradiated human lung adenocarcinoma epithelial cells.BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instabilityhSSB1 rapidly binds at the sites of DNA double-strand breaks and is required for the efficient recruitment of the MRN complex.Investigation into the radiobiological consequences of pre-treatment verification imaging with megavoltage X-rays in radiotherapyRadiation-induced bystander signalling in cancer therapy.Microbeam studies of the bystander responseA kinetic-based model of radiation-induced intercellular signalling.Small animal image-guided radiotherapy: status, considerations and potential for translational impact.Use of the γ-H2AX assay to investigate DNA repair dynamics following multiple radiation exposures.Radiation-induced bystander effects. Mechanisms, biological implications, and current investigations at the Leipzig LIPSION facility.Mechanisms of DNA damage response to targeted irradiation in organotypic 3D skin cultures.Bystander responses induced by low LET radiation.The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy.Imaging and radiation effects of gold nanoparticles in tumour cellsWhat role for DNA damage and repair in the bystander response?New advances in radiation biology.Direct evidence for a bystander effect of ionizing radiation in primary human fibroblastsInvestigating the Implications of a Variable RBE on Proton Dose Fractionation Across a Clinical Pencil Beam Scanned Spread-Out Bragg PeakVariations in the Processing of DNA Double-Strand Breaks Along 60-MeV Therapeutic Proton Beams.ATM acts downstream of ATR in the DNA damage response signaling of bystander cellsDelivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer ProgramIonizing radiation-induced bystander mutagenesis and adaptation: quantitative and temporal aspects.Targeted cytoplasmic irradiation induces bystander responses.Pro-inflammatory Signaling in a 3D Organotypic Skin Model after Low LET Irradiation-NF-κB, COX-2 Activation, and Impact on Cell Differentiation.Concise review: stem cell effects in radiation risk.Physical basis and biological mechanisms of gold nanoparticle radiosensitization.High dose bystander effects in spatially fractionated radiation therapy.A proliferation-dependent bystander effect in primary porcine and human urothelial explants in response to targeted irradiation.Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.Immune modulation in advanced radiotherapies: Targeting out-of-field effects.Low-dose radiation-induced risk in spermatogenesis.Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy.FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung Cancer.
P50
Q26825698-0C181E8F-991E-4B62-B555-0AB8A47322DEQ28066413-77025335-92F0-4B13-A819-FC09FB644CDCQ28728371-DAF15789-10B2-4A5E-99B8-5162C13C944CQ29248405-7A37DC2B-B9E1-4A71-9760-EB0633923E1DQ30886928-1FA5F42D-99B0-489B-961E-5CFD92F81353Q33347854-ADE40DAA-41B2-4D44-B222-D7BA53F4F481Q33524659-70AC74DE-9032-451A-BBD2-429B04E1AB43Q33566784-E085E2DF-0F72-46FC-ABCA-74D34E09A414Q33624839-7FA56E10-7F88-44C9-AC77-4E9969920EE3Q33738564-6B42D271-8FA0-4AA2-A433-484FCB2B1F76Q33792270-1654EAC4-3CEA-4DC3-8817-C7EDE46DCA63Q33794726-0A91639C-4634-4FFC-B781-CEDA8192D34CQ33794741-0F018D6F-C595-4269-876B-62CD3ECE269DQ34563252-6C1FACF5-27D0-4EDB-910A-95E1E50D33ACQ34776573-F36D34FA-E906-4828-8209-F9F1FC2D9D95Q35060189-8E490962-8B45-4336-834D-E91EE66E152CQ35067841-A8EFC2A7-1194-44AC-97C4-F1BC2EBCBCD1Q35088055-17B518BD-9A13-4514-AE4B-A0D4F869987FQ35559140-1DE81F8A-423E-40EF-96B1-C44431A82F34Q35676729-5824E869-7669-4F13-AE68-2C01B13E81C9Q35898483-48C0BEEA-D06F-48BE-A678-416A6F34A169Q36368987-D1257916-9B44-43EA-BE53-1600F3D620FFQ36461276-E45AFC7D-784D-4C95-A61F-B398D99E7AE9Q36622741-E2A3B166-DD76-45DA-93C6-54E4C9F8700EQ36818883-A3714B61-4A26-4271-8EC6-6980E69532ABQ36823746-E7EEB7BF-0F66-4E6C-A98D-08DE8EFEFA58Q36859010-8DB0D73B-F264-4C93-9646-28433A8572F1Q36893736-7D15F4F0-20B0-47DE-A43F-8635409B7966Q37441409-F315A6F8-803A-4616-8D6A-9220EBA3B151Q37534708-69ECDCDC-A10F-4ACC-BC7F-5E0FF6E025C5Q37634652-1760C69D-3A95-4AD2-AA2F-039A3764AD67Q37900926-1ACBFC57-D72E-4032-80C5-1587C26D237CQ38024325-3D584CEE-4041-484D-A668-6D9391D2FBB7Q38163718-E567BA62-BC85-4F50-9838-B0A5DC7E9518Q38293943-23E72EA9-15F6-40CC-AA79-7C194C269596Q38419991-836546D8-22F3-4C01-9796-6FA21C72DB52Q38429240-3FFD1D65-472F-4A23-B912-322653B597E8Q38648574-A810E6D3-5649-426B-A8BE-A1915B7F48BBQ38697545-08453A29-6C2C-4543-94B4-8CDFFF2A515CQ38754740-0FE8FB89-BFA4-4402-9DA6-A3771F24A24E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kevin M. Prise
@ast
Kevin M. Prise
@en
Kevin M. Prise
@es
Kevin M. Prise
@nl
Kevin M. Prise
@sl
type
label
Kevin M. Prise
@ast
Kevin M. Prise
@en
Kevin M. Prise
@es
Kevin M. Prise
@nl
Kevin M. Prise
@sl
altLabel
Prise KM
@en
prefLabel
Kevin M. Prise
@ast
Kevin M. Prise
@en
Kevin M. Prise
@es
Kevin M. Prise
@nl
Kevin M. Prise
@sl
P1053
N-7872-2015
P106
P1153
7005557662
P21
P2798
P31
P3829
P496
0000-0001-6134-7946